2020 ASCO Virtual Direct™ Highlights
Playback speed
10 seconds
2020 ASCO Low-grade Lymphoma Highlights: Is CD19 CAR-T Axi-cel Active in R/R Indolent NHLs? Does BOVen (Zanubrutinib, Obinutuzumab, Venetoclax) Achieve Frequent uMRD in 1L CLL? Is 2nd Generation BTKi Zanubrutinib Better Than Ibrutinib in WM?
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Jake Soumerai
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Jake Soumerai
567 views
July 22, 2020
Comments 0
Login to view comments.
Click here to Login
Hematologic Oncology